An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19
- 1 September 2020
- journal article
- letter
- Published by Elsevier in Clinica Chimica Acta
- Vol. 508, 213-216
Abstract
No abstract availableKeywords
Funding Information
- Shiraz University
This publication has 10 references indexed in Scilit:
- Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosisClinica Chimica Acta, 2020
- COVID-19: Melatonin as a potential adjuvant treatmentLife Sciences, 2020
- The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infectionsClinica Chimica Acta, 2020
- Redox Biology of Respiratory Viral InfectionsViruses, 2018
- Effect of melatonin supplementation and cross-fostering on renal glutathione system and development of hypertension in spontaneously hypertensive ratsJournal of Physiology and Biochemistry, 2013
- Cruciferous Vegetable Consumption and Lung Cancer Risk: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2009
- Relevance of the Deletion Polymorphisms of the Glutathione S-Transferases GSTT1 and GSTM1 in Pharmacology and ToxicologyCurrent Drug Metabolism, 2006
- The effect of melatonin on glutathione and glutathione transferase and glutathione peroxidase activities in the mouse liver and kidney in vivo.2006
- Purification, characterization and tissue distribution of human class theta glutathione s-transferase T1-1IUBMB Life, 1996
- Immunohistochemical localization of glutathione S-transferases in human lung.1993